Peer-influenced content. Sources you trust. No registration required. This is HCN.
Clinical Infectious Diseases (CID)
A retrospective quasi-experimental study at St. Jude Children’s Research Hospital found that discontinuing empiric antibiotics within 72 hours of febrile neutropenia onset in clinically stable pediatric haploidentical HCT recipients reduced antibiotic exposure by a median of 8 days without significant differences in bloodstream infection, ICU admission, or mortality.
Pediatrics June 17th 2026
Annals of Internal Medicine
The primary end point was the area under the curve (AUC) of the daily worst bone pain score (assessed using the “worst pain” question from the Brief Pain Inventory, a 0 to 10 numerical rating scale [NRS]) for 5 consecutive days in the first chemotherapy cycle.
Hematology/Oncology March 30th 2026
Journal of Clinical Pathways
This comprehensive research highlights favorable outcomes with Cigna’s home-redirection program for pegfilgrastim administration in CIN prophylaxis, including a 32% reduction in specific complications. Explore how this study may influence future healthcare delivery models, enhancing both clinical efficacy and affordability.
Hematology/Oncology August 1st 2023
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS